Cystagon product information

Introduction

This is a summary of the European Public Assessment Report (EPAR) for Cystagon. It explains how the Committee for Medicinal Products for Human Use (CHMP) evaluated the drug to arrive at a positive opinion for granting a marketing authorization and its recommendations for the conditions of use for Cystagon.

View product information

Don't miss our upcoming events